Welcome to our dedicated page for Ethema Hlth news (Ticker: GRST), a resource for investors and traders seeking the latest updates and insights on Ethema Hlth stock.
Ethema Health Corporation (OTCPINK: GRST) is a behavioral healthcare company focused on the treatment of substance use disorders, with operations centered on in-patient treatment for adults. Through its ARIA (Addiction Recovery Institute of America) subsidiary and managed operations in Florida and Kentucky, the company regularly releases news about facility licensing, expansion, and corporate developments.
On this page, readers can follow Ethema’s announcements about new and expanded treatment facilities, such as ARIA’s licensed inpatient detoxification and Residential Level 1 center in Boca Raton, Florida, and updates related to the management and planned acquisition of Edgewater Recovery Center in Kentucky. These items provide insight into the company’s growing treatment capacity, regulatory milestones, and the populations it serves, including Medicaid insured clients in Kentucky.
Ethema also issues news about its participation in investor conferences, including The Microcap Conference and Emerging Growth healthcare events, where management presents on growth strategy, acquisitions, financing plans, and its behavioral health platform. These releases offer context on how the company communicates with shareholders and potential investors.
By reviewing the Ethema Health Corporation (GRST) news feed, investors and observers can track developments in its substance use disorder treatment operations, licensing progress, bed capacity expansion, and capital markets outreach. This page brings together company-issued updates in one place for convenient reference.
Ethema Health (OTCPINK:GRST) has announced its participation in The Microcap Conference 2025, scheduled for January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ. This premier event brings together growth-focused companies and investors.
The company's management team will deliver a corporate presentation and conduct one-on-one meetings with institutional and individual investors. During these sessions, they will discuss recent developments, growth strategy, and investment opportunities.
Notably, Ethema has exceeded all projections made at the 2024 Microcap conference. Mr. Leon will present details about the significant impact of the company's recently acquired Kentucky business and outline the outlook for 2025 and beyond.
Ethema Health 's subsidiary ARIA received a full license for inpatient detoxification and Residential Level 1 facility in Boca Raton on October 21, 2024. The ARIA Boca facility features 11 detox beds and 12 residential beds, increasing total Florida bed count to 85. While Q3 revenue from ARIA Boca was delayed pending insurer contract updates, ARIA's Q3 2024 revenues grew 18% from Q2 2024 and 30% from Q3 2023. The company expects ARIA Boca revenue generation in Q4 2024 and plans to complete the Edgewater Recovery center acquisition in Kentucky during the same quarter. Management aims for an uplisting in H1 2025.
Ethema Health (OTCPINK: GRST) has signed a binding Asset Purchase Agreement to acquire the business operations and operational assets of Edgewater Recovery Center, (ERC) in Kentucky. The transaction excludes real property and requires various consents. ERC has been managed by Ethema since July 15, 2024, and will continue operations until ARIA Kentucky, a new subsidiary, is fully licensed and accredited.
The current ERC patient census is approximately 195 patients, with expectations of significant growth. Ethema plans to add 16 beds in October at the Paducah location. ARIA Kentucky will primarily serve Medicaid-insured clients, with potential for expansion due to ongoing investigations into other Medicaid providers in the state.
The real property associated with ERC operations will be acquired separately by a fund controlled by Ethema's CEO, Shawn Leon, and leased to ARIA Kentucky at market rates.
Ethema Health (OTCPINK: GRST) has received a license for its new 16-bed inpatient detoxification and 16-bed residential level 1 facility in Boca Raton, Florida. This increases the company's total bed count in Florida to 94. Ethema is also negotiating to purchase facilities in Kentucky, potentially adding 60 more beds.
The company is considering setting up a separate Real Estate Fund and plans to announce a new Preferred Stock offering. CEO Shawn Leon will present at the 1640 Society gathering in Southampton, New York. Ethema has reset its growth target to 3,000 beds by the end of 2027. The company is also discussing potential up-listing, a convertible preferred stock offering, and future cash dividends.
Ethema Health (OTCPINK: GRST) is set to present at the Emerging Growth Healthcare Conference on July 18, 2024 at 10:15 AM Eastern time. CEO Shawn Leon will discuss the company and the effects of the recently announced LOI for the purchase and management of Edgewater Recovery Center .
The live, interactive online event allows shareholders and investors to engage with the CEO in real-time. Attendees can submit questions in advance or during the event. Registration is required to attend and receive updates.
Additionally, Shawn Leon was interviewed by SaveChangeWorld.com on July 14, 2024, primarily discussing Ethema's acquisition of Edgewater Recovery Center. The recorded interview, available on their website, includes projections and Ethema's ongoing financing strategy.
Ethema Health (GRST) has signed a Letter of Intent (LOI) to acquire all assets of Edgewater Recovery Center (ERC), including three real estate holding companies. The agreement also includes a management deal effective July 15, 2024, until the acquisition closes on January 31, 2025. ERC operates in Morehead and Paducah, Kentucky, with around 440 licensed beds and an additional 66 beds coming online in 2024. The acquisition is expected to help Ethema reach its goal of 500 beds by the end of 2025. The deal will also allow Ethema to pursue a sale-leaseback transaction for working capital without new equity. Ethema’s CEO, Shawn Leon, highlighted the strategic benefits, including expanding Medicaid-insured care and up-listing plans.
Summary not available.
Summary not available.
Summary not available.
Summary not available.